Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 2,903 | 3,261 | 3,542 | 2,621 | 2,670 |
| Operating Income | -2,903 | -3,261 | -3,542 | -2,621 | -2,670 |
| Pre-tax Income | -2,903 | -3,261 | -3,542 | -2,621 | -2,670 |
| Net Income Continuous | -2,903 | -3,261 | -3,542 | -2,621 | -2,670 |
| Net Income | $-2,903 | $-3,261 | $-3,542 | $-2,621 | $-2,670 |
| EPS Basic Total Ops | -5.00 | -5.60 | -6.40 | -5.20 | -5.20 |
| EPS Basic Continuous Ops | -4.99 | -5.68 | -6.35 | -5.11 | -5.22 |
| EPS Diluted Total Ops | -5.00 | -5.60 | -6.40 | -5.20 | -5.20 |
| EPS Diluted Continuous Ops | -4.99 | -5.68 | -6.35 | -5.11 | -5.22 |
| EBITDA(a) | $-2,903 | $-3,261 | $-3,542 | $-2,621 | $-2,670 |